These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 25815687

  • 1. MicroRNA-133a inhibits proliferation and invasion, and induces apoptosis in gastric carcinoma cells via targeting fascin actin-bundling protein 1.
    Lai C, Chen Z, Li R.
    Mol Med Rep; 2015 Jul; 12(1):1473-8. PubMed ID: 25815687
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-145 and MicroRNA-133a Inhibited Proliferation, Migration, and Invasion, While Promoted Apoptosis in Hepatocellular Carcinoma Cells Via Targeting FSCN1.
    Wang G, Zhu S, Gu Y, Chen Q, Liu X, Fu H.
    Dig Dis Sci; 2015 Oct; 60(10):3044-52. PubMed ID: 26173501
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA‑145 inhibits the malignant phenotypes of gastric carcinoma cells via downregulation of fascin 1 expression.
    Xue M, Zhao L, Yang F, Li Z, Li G.
    Mol Med Rep; 2016 Jan; 13(1):1033-9. PubMed ID: 26647829
    [Abstract] [Full Text] [Related]

  • 4. The role of microRNA-133b and its target gene FSCN1 in gastric cancer.
    Guo L, Bai H, Zou D, Hong T, Liu J, Huang J, He P, Zhou Q, He J.
    J Exp Clin Cancer Res; 2014 Nov 30; 33(1):99. PubMed ID: 25433493
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-145 inhibits migration and invasion via inhibition of fascin 1 protein expression in non-small-cell lung cancer cells.
    Zhang Y, Yang X, Wu H, Zhou W, Liu Z.
    Mol Med Rep; 2015 Oct 30; 12(4):6193-8. PubMed ID: 26238532
    [Abstract] [Full Text] [Related]

  • 6. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
    Kano M, Seki N, Kikkawa N, Fujimura L, Hoshino I, Akutsu Y, Chiyomaru T, Enokida H, Nakagawa M, Matsubara H.
    Int J Cancer; 2010 Dec 15; 127(12):2804-14. PubMed ID: 21351259
    [Abstract] [Full Text] [Related]

  • 7. miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer.
    Chiyomaru T, Enokida H, Tatarano S, Kawahara K, Uchida Y, Nishiyama K, Fujimura L, Kikkawa N, Seki N, Nakagawa M.
    Br J Cancer; 2010 Mar 02; 102(5):883-91. PubMed ID: 20160723
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. MicroRNA-133a functions as a tumor suppressor in gastric cancer.
    Xu XC, Zhang YH, Zhang WB, Li T, Gao H, Wang YH.
    J Biol Regul Homeost Agents; 2014 Mar 02; 28(4):615-24. PubMed ID: 25620172
    [Abstract] [Full Text] [Related]

  • 15. Promoter Methylation-Regulated miR-145-5p Inhibits Laryngeal Squamous Cell Carcinoma Progression by Targeting FSCN1.
    Gao W, Zhang C, Li W, Li H, Sang J, Zhao Q, Bo Y, Luo H, Zheng X, Lu Y, Shi Y, Yang D, Zhang R, Li Z, Cui J, Zhang Y, Niu M, Li J, Wu Z, Guo H, Xiang C, Wang J, Hou J, Zhang L, Thorne RF, Cui Y, Wu Y, Wen S, Wang B.
    Mol Ther; 2019 Feb 06; 27(2):365-379. PubMed ID: 30341010
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. miR-200b inhibits migration and invasion in non-small cell lung cancer cells via targeting FSCN1.
    Xiao P, Liu W, Zhou H.
    Mol Med Rep; 2016 Aug 06; 14(2):1835-40. PubMed ID: 27356635
    [Abstract] [Full Text] [Related]

  • 19. Loss of miR-133a expression associated with poor survival of breast cancer and restoration of miR-133a expression inhibited breast cancer cell growth and invasion.
    Wu ZS, Wang CQ, Xiang R, Liu X, Ye S, Yang XQ, Zhang GH, Xu XC, Zhu T, Wu Q.
    BMC Cancer; 2012 Feb 01; 12():51. PubMed ID: 22292984
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.